The first release of MolBook UNIPI software is now available!

29/01/2023 – MolBook UNIPI is a software developed by our group for the academic and research community, to deal with data aimed to compose, manage and analyze databases containing information related to chemical compounds, to take advantage of various properties including the prediction of the toxicological profile of molecules.

For further information visit the MolBook UNIPI website!

TOTEM project funded by the University of Pisa

13/01/2023 – University Pisa, The University of Pisa has funded the TOTEM – Therapeutic protac targeting MAGL project, which will provide for the patenting of the first PROTAC anti monoacylglycerol lipase.

For more info:

Top-cited scientists

18/11/2022 – Prof. Tiziano Tuccinardi has been included in the list of the 1% top scientists for the Medicinal & Biomolecular Chemistry field (ranked 642 out of 94672 scientists); as reported by: Ioannidis, John P.A. September 2022 data-update for “Updated science-wide author databases of standardized citation indicators.” 2022, Mendeley Data, V5, doi: 10.17632/btchxktzyw.5

For more info:

Congratulations to our PhD student Miriana Di Stefano for her presentation at RDKit UGM2022

12/10/2022 – Miriana Di Stefano, a doctoral student of the mmvsl group, has taken part in 11th RDKit UGM2022 Conference in Berlin presenting VenomPred Platform with an oral presentation and a poster.

For more details:

Congratulations to our doctoral student Salvatore Galati for his presentation at MMCS 2022

08/09/2022 – Salvatore Galati, a PhD student gave an oral comunication entitled “VenomPred: A Machine Learning Based Platform for Molecular Toxicity Predictions” at the MMCS 2022 meeting (

Congratulations to postdoc researcher Giulia Bononi for being awarded a TUMA2022 travel grant

02/09/2022 – Giulia Bononi, a postdoc reseracher of the mmvsl group has been awarded a TUMA2022 travel grant. At this meeting ( she gave an oral comunication entitled “Identification of a new series of reversible MAGL inhibitors based on a benzylpiperidine scaffold.”